Eris Lifesciences made its Q4 and FY26 earnings conference call recording available on its website in regulatory compliance.
The call was held on May 20, 2026, to discuss audited standalone and consolidated financial results.
The disclosure was formally communicated to BSE and NSE as required by SEBI LODR Regulations.